Interim / Quarterly Report • Oct 7, 2022
Interim / Quarterly Report
Open in ViewerOpens in native device viewer

www.prodways-group.com
1 Net cash flow from operating activities before changes in working capital.
Since its creation, Prodways Group has focused on technologies serving industrial production for mass manufacturing. The company's expertise in printers was quickly complemented by the development of 3D materials and print-on-demand activities. The joint work of these teams, for nearly 10 years, has enabled Prodways to offer one of the most reliable technologies on the market for industrial production. The performance and quality of Prodways Machines & Materials have enabled the group to win international tenders in Europe, the USA and Asia-Pacific.
Prodways has also been able to focus at the right time on supportive markets in 3D printing. In particular, it has focused on the needs of the medical sector since 2014, which is now the largest consumer of 3D printing and offers significant opportunities against the backdrop of the digitalization of its processes. Prodways Group is now one of the world's reference players in 3D printing for the dental sector. Overall, customers in the medical sector now represent nearly 50% of Prodways' revenues.
These development paths have enabled Prodways to build up a significant base of recurring revenues, representing around 65% of revenues at the end of June 2022. These include recurring consumption of 3D materials, which has been rising sharply for several years, as well as recurring orders from numerous customers equipped with Prodways solutions, such as the network of over 1,000 audiologists in France.
The strong revenue growth of 22% in the first half of 2022 was accompanied by a clear improvement in Prodways Group's profitability across all its indicators (current EBITDA, operating profit, cash generation). Prodways' strategy of pursuing both revenue growth and profitability is now proving its relevance in a context of rising interest rates and concerns about the sustainability of certain 3D printing companies that are still loss-making.

Since the launch of its activities in 2014, Prodways has achieved an average revenue growth of +46% per year, combining organic and external growth. At the same time, the current EBITDA margin has increased from -42% in 2014 to +19% in the first half of 2022, reaching €7.9 million. This result materialized in cash generation of +6.9 M€2 , 16% more than for the full year 2021. This financial performance makes Prodways the most profitable company among the main listed 3D companies3 .
This financial strength confers significant competitive advantages to accelerate its growth trajectory, such as:
| (in €million) | H1 2021 | H1 2022 | Variation (€m) |
Variation (%) |
|---|---|---|---|---|
| Revenues | 34,1 | 41,5 | +7,4 | +22% |
| Current EBITDA | 4,5 | 7,9 | +3,4 | +75% |
| Current EBITDA margin (%) | 13,2% | 19,0% | - | +6 pts |
| Income from ordinary activities | 2,2 | 5,4 | +3,2 | +146% |
| Operating income | 0,9 | 5,1 | +4,2 | +495% |
| Financial results, tax and minorities interest | -1,2 | -1,6 | -0,4 | n.a |
| Net result in group share | -0,3 | 3,5 | +3,8 | n.a |
2 Net cash flow from operating activities before changes in working capital
3 Comparison of H1 2022 current EBITDA margin of 22 listed companies in North America, Europe and Asia, excluding China (PWG, DDD, SSYS, DM, MKFG, SLM, XMTR, VLD, VJET, PRLB, MTLS, SHPW, NNDM, STKH, ONVO, FATH, NORSF, CFMS, FSRD, A3D, TTT, XAR)
Prodways Group achieved strong revenue growth in the first half of 2022, driven by both organic growth of +15% and the momentum of external growth. This performance is the combined result of:
More details on the evolution of revenues are available in the dedicated press release of July 25, 2022.
Prodways Group generated current EBITDA of €7.9 million in the first half of 2022, up 75% compared to the first half of 2021.
This improvement is the result of several factors:
The consolidated financial statements are available in the appendix at the end of this press release.
4 As a reminder, Prodways Group also benefited from a waiver of €0.9 million in the first half of 2021.
Prodways is positioned as one of the few profitable companies in the 3D printing sector and has consolidated its balance sheet to support the foundations of sustainable growth. The Group's cash flow from operations reached €6.9 million in the first half of 2022, more than three times the amount generated in the first half of 2021 and already 16% higher than the amount generated over the full year 2021.
This performance is partially offset by the higher-than-normal change in working capital (+€3.4 million in H1 2022, to €3.8 million). This increase is explained by a rise in inventories as a precautionary measure for production needs, as well as the impact of the change in seasonality due to anticipated sales in the Software activity. The level of working capital should decrease by the end of the year back to a normal level of around 3% to 4% of annual revenues.
In the end, the Group is still in a positive net cash position (of €1.8 million), with €19 million of cash available at the end of June 202.
| (in €million) | H1 2021 | H1 2022 | Variation €m |
Variation % |
|
|---|---|---|---|---|---|
| Revenues | 21,6 | 26,4 | +4,8 | 22% | |
| Current EBITDA | 3,5 | 6,0 | +2,5 | 71% | |
| Systems | Current EBITDA margin (%) | 16,3% | 22,7% | 6,4 pts | - |
| Income from ordinary activities | 2,5 | 5,0 | +2,5 | - | |
| Revenues | 12,6 | 15,3 | +2,7 | 21% | |
| Current EBITDA | 1,4 | 2,3 | +0,9 | 64% | |
| Products | Current EBITDA margin (%) | 11,2% | 15,1% | 3,9 pts | |
| Income from ordinary activities | 0,0 | 0,8 | +0,8 |
Prodways' Systems Division achieved a number of successes this semester, particularly in its Machines & Materials activity. The performance of the MovingLight® LD printers, the second generation of this technology, combined with Prodways' proprietary 3D resins (such as the Absolute Aligner resin), is now recognized by many players in the dental sector worldwide. The productivity of the machines, their precision over several years and the quality of the finished products are setting references in the market and have enabled Prodways to win industrial projects for multi-machine production sites. In addition to new customers, almost all of the group's existing customers are increasing their consumption of materials, taking advantage of the buoyant medical market.
These commercial successes, following on from those of 2021, have led to a strong expansion of Prodways' international business. France now accounts for only 12% of Machines & Materials revenues, while North America now accounts for 1/3 of revenues.

The Systems Division's revenues are up by +22% this half-year compared to the first half of 2021. This performance is the combined result of:
On the back of this strong revenue growth, this division achieved a current EBITDA margin of 23% this half-year, up +6 pts compared with the 1st half of 2021. This profitability is supported by good control of gross margins, the reduction in indirect costs as a proportion of revenues and the growing contribution of material sales. It was enhanced this halfyear by the waiver of a debt in the United States in the context of public support during the health crisis, representing an impact of +€0.9 million.
This activity, which was slow to recover from the crisis last year, has grown organically by +8% and +47% including the acquisition of Creabis. This activity benefits from four growth levers:
5 Revenues generated in H1 2022 by customers who should have renewed their SOFTWARE licenses mainly in H2 2022.
The development of this activity has been accelerated by the acquisition of Creabis, whose successful integration is generating twice as many synergies as initially planned. The pooling of resources has made the new entity's offering more attractive and has resulted in a cross-selling volume that is well above expectations.
In total, nearly 55% of the Digital Manufacturing business' revenues are now generated from French customers and nearly 45% from foreign customers, notably in Germany, Italy and Switzerland.
Integrated medical activities, in which Prodways offers complete digital solutions from impression taking to delivery to the client (practitioner or end user), are driven by the performance of audiology. It accounts for nearly 75% of the revenues of this segment, taking into account the recent acquisition.
Revenue growth was driven in particular by past commercial successes, which are having an impact this half-year. Prodways forged some twenty new partnerships with emblematic customers (such as EDF, Bouygues, Yves Rocher, Aéroports de Paris, SNCF, Derichebourg, Colas, BIC, etc.) to equip their employees with hearing protection. This momentum is now reinforced by the acquisition of Auditech Innovations, completed in early July 2022.
Along with the 21% revenue growth, the Products division generated a current EBITDA of €2.3 million in the first half of the year, up 64%. The current EBITDA margin reached 15% and reflects:
Thanks to this progress, the Products Division has achieved generated the highest income from ordinary operations of its history with €0.8 million.
At the end of July 2022, Prodways Group raised its revenue guidance for the year 2022, now targeting growth of around +15% including recent acquisitions (compared with "around 10%" previously).
The group's profitability, adjusted for exceptional items in the first half of the year, should remain at its current level. Prodways Group is therefore targeting a current EBITDA margin of between 15% and 20% for the full year 2022.
| (in thousands of euros) | Notes | 30/06/2022 | 30/06/2021 | 31/12/2021 |
|---|---|---|---|---|
| NON-CURRENT ASSETS | 72,743 | 67,607 | 73,203 | |
| Goodwill | 6.1 | 41,831 | 38,094 | 41,831 |
| Other intangible assets | 6.2 | 11,936 | 10,243 | 11,033 |
| Property, plant and equipment | 6.3 | 16,039 | 16,386 | 16,815 |
| Investments in affiliated companies | 8.4 | 1,285 | 1,216 | 1,213 |
| Other financial assets | 782 | 840 | 815 | |
| Deferred tax assets | 9.2 | 870 | 829 | 1,496 |
| CURRENT ASSETS | 44,645 | 41,640 | 40,464 | |
| Net inventories | 4.2 | 8,006 | 6,055 | 6,502 |
| Net trade receivables | 4.3 | 13,063 | 11,230 | 12,175 |
| Contract assets | 4.3 | 48 | - | 20 |
| Other current assets | 4.4 | 2,796 | 2,073 | 3,049 |
| Tax receivables payable | 9.1 | 1,865 | 2,194 | 1,802 |
| Cash and cash equivalents | 8.2 | 18,868 | 20,088 | 16,917 |
| ASSETS HELD FOR SALE | - | - | - | |
| TOTAL ASSETS | 117,389 | 109,247 | 113,668 |
| (in thousands of euros) | Notes | 30/06/2022 | 30/06/2021 | 31/12/2021 |
|---|---|---|---|---|
| EQUITY ATTRIBUTABLE TO OWNERS OF THE PARENT |
68,893 | 63,599 | 64,812 | |
| Capital(1) | 10.1 | 25,632 | 25,632 | 25,632 |
| Share premiums(1) | 85,755 | 85,404 | 85,617 | |
| Retained earnings and consolidated net income | (42,494) | (47,437) | (46,438) | |
| NON-CONTROLLING INTERESTS | 38 | (150) | 41 | |
| NON-CURRENT LIABILITIES | 21,156 | 21,594 | 20,215 | |
| Long-term provisions | 5.2 | 691 | 1,133 | 949 |
| Long-term liabilities – portion due in more than one year | 8.1 | 14,424 | 14,212 | 13,031 |
| Lease liabilities – portion due in more than one year | 8.3 | 5,356 | 5,757 | 5,698 |
| Deferred tax liabilities | 9.2 | 684 | 492 | 538 |
| Other non-current liabilities | - | - | - | |
| CURRENT LIABILITIES | 27,302 | 24,205 | 28,601 | |
| Short-term provisions | 11 | 806 | 1,228 | 927 |
| Long-term liabilities – portion due in less than one year | 8.1 | 2,787 | 2,201 | 2,721 |
| Lease liabilities – portion due in less than one year | 8.3 | 1,701 | 1,742 | 1,779 |
| Operating payables | 4.5 | 7,697 | 7,193 | 9,155 |
| Contract liabilities | 4.3 | 2,086 | 617 | 1,585 |
| Other current liabilities | 4.5 | 11,731 | 10,845 | 12,273 |
| Tax liabilities payable | 9.1 | 493 | 380 | 161 |
| LIABILITIES HELD FOR SALE | - | - | - | |
| TOTAL LIABILITIES | 117,389 | 109,247 | 113,668 |
(1) Of the consolidating parent company.
| (in thousands of euros) | Notes | 30/06/2022 | 30/06/2021 | 31/12/2021 |
|---|---|---|---|---|
| REVENUE | 3.2 | 41,470 | 34,118 | 70,645 |
| Capitalized production | 1,116 | 645 | 1,510 | |
| Inventories and work in progress | 111 | (531) | (555) | |
| Other income from operations | 1,066 | 1,105 | 1,937 | |
| Purchases consumed | (20,448) | (16,326) | (35,319) | |
| Personnel expenses | (15,298) | (14,196) | (28,422) | |
| Tax and duties | (326) | (372) | (767) | |
| Depreciation, amortization, and provisions (net of reversals) | 4.1 | (2,494) | (2,307) | (4,491) |
| Other operating expenses net of income | 195 | 60 | (226) | |
| OPERATING RESULT | 5,393 | 2,196 | 4,312 | |
| Group share of the earnings of affiliated companies | 71 | 82 | 79 | |
| Non-recurring items in operating income | 3.1 | (393) | (1,425) | (2,610) |
| OPERATING INCOME | 5,071 | 852 | 1,782 | |
| Interest on gross debt | (112) | (91) | (206) | |
| Interest on cash and cash equivalents | - | 3 | - | |
| COST OF NET DEBT (a) | 8.6 | (112) | (88) | (206) |
| Other financial income (b) | 150 | 55 | 179 | |
| Other financial expense (c) | (134) | (45) | (148) | |
| FINANCIAL INCOME AND EXPENSES (d = a + b + c) | 8.6 | (97) | (78) | (176) |
| Income tax | 9.1 | (1,504) | (1,171) | (1,054) |
| NET INCOME FROM CONTINUING OPERATIONS AFTER TAX | 3,470 | (397) | 552 | |
| Net income from discontinued operations | - | - | - | |
| CONSOLIDATED NET INCOME | 3,470 | (397) | 552 | |
| INCOME ATTRIBUTABLE TO THE PARENT'S SHAREHOLDERS | 3,468 | (325) | 626 | |
| INCOME ATTRIBUTABLE TO NON-CONTROLLING INTERESTS | 2 | (72) | (74) |
| Average number of shares | 10.2 | 51,225,160 | 51,220,596 | 51,218,493 |
|---|---|---|---|---|
| Basic earnings per share (in euros) | 10.2 | 0.068 | (0.006) | 0.012 |
| Diluted earnings per share (in euros) | 10.2 | 0.067 | (0.006) | 0.012 |
| (in thousands of euros) | 30/06/2022 | 30/06/2021 | 31/12/2021 |
|---|---|---|---|
| NET INCOME | 3,470 | (397) | 552 |
| Translation differences | 340 | 69 | 167 |
| Tax relating to translation differences | (63) | (1) | - |
| Actuarial gains and losses on defined benefit plans | 236 | 18 | 63 |
| Tax relating to actuarial gains and losses on defined benefit plans | (59) | (5) | (16) |
| TOTAL GAINS AND LOSSES RECOGNIZED IN EQUITY | 454 | 81 | 214 |
| - of which can be reclassified subsequently to profit and loss |
277 | 68 | 167 |
| - of which cannot be subsequently reclassified to profit and loss |
177 | 13 | 47 |
| CONSOLIDATED COMPREHENSIVE INCOME | 3,925 | (316) | 766 |
| COMPREHENSIVE INCOME ATTRIBUTABLE TO PARENT COMPANY SHAREHOLDERS |
3,928 | (244) | 846 |
| COMPREHENSIVE INCOME ATTRIBUTABLE TO NON-CONTROLLING INTERESTS |
(3) | (72) | (79) |
| (in thousands of euros) | 30/06/2022 | 30/06/2021 | 31/12/2021 |
|---|---|---|---|
| NET INCOME FROM CONTINUING OPERATIONS | 3,470 | (397) | 552 |
| Accruals | 1,835 | 1,420 | 4,348 |
| Capital gains and losses on disposals | 17 | (76) | (149) |
| Group share of income of equity-accounted companies | (71) | (82) | (79) |
| CASH FLOW FROM OPERATING ACTIVITIES (before neutralization of the cost of net financial debt and taxes) |
5,251 | 865 | 4,672 |
| Cost of net debt | 112 | 88 | 206 |
| Tax expense | 1,504 | 1,171 | 1,054 |
| CASH FLOW FROM OPERATING ACTIVITIES (before neutralization of the cost of net financial debt and taxes) |
6,867 | 2,124 | 5,933 |
| Tax paid | (853) | (697) | (1,267) |
| Change in working capital | (3,362) | (2,211) | (835) |
| NET CASH FLOW FROM OPERATING ACTIVITIES (A) | 2,652 | (784) | 3,831 |
| Investing activities | |||
| Payment/acquisition of intangible assets | (1,223) | (714) | (1,513) |
| Payment/acquisition of property, plant and equipment | (380) | (383) | (1,608) |
| Proceeds/disposal of property, plant and equipment and intangible assets | 11 | 81 | 169 |
| Payment/acquisition of financial investments | (9) | (32) | (35) |
| Proceeds/disposal of financial investments | 44 | 49 | 84 |
| Net cash inflow/outflow on the acquisition/disposal of subsidiaries | (225) | - | (3,394) |
| NET CASH FLOW FROM INVESTING ACTIVITIES (B) | (1,783) | (999) | (6,297) |
| Financing activities | |||
| Capital increase or contributions | - | - | - |
| Dividends paid to parent company shareholders | - | - | - |
| Other equity transactions | 22 | (21) | (43) |
| Proceeds from borrowings | 2,968 | 1,214 | 1,208 |
| Repayments of borrowings and lease liabilities | (1,840) | (1,766) | (4,143) |
| Cost of net debt | (112) | (86) | (200) |
| NET CASH FLOW FROM FINANCING ACTIVITIES (C) | 1,038 | (659) | (3,179) |
| CASH FLOW GENERATED BY OPERATING ACTIVITIES (D = A + B + C) |
1,907 | (2,442) | (5,644) |
| Cash flow generated by discontinued operations | - | - | - |
| CHANGE IN CASH AND CASH EQUIVALENTS | 1,907 | (2,442) | (5,644) |
| Effects of exchange rate changes | 36 | 29 | 64 |
| CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE YEAR | 16,897 | 22,478 | 22,478 |
| CASH AND CASH EQUIVALENTS AT THE END OF THE YEAR | 18,841 | 20,065 | 16,897 |
| (in thousands of euros) | Group share or owners of the parent company | ||||||
|---|---|---|---|---|---|---|---|
| Capital | Share capital reserves | Treasury shares | and earnings excluding Consolidated reserves treasury shares |
Equity attributable to owners of the parent |
minority interests or non- Equity attributable to controlling interests |
Total equity | |
| 2020 CLOSING EQUITY | 25,539 | 85,040 | (103) | (46,810) | 63,665 | (276) | 63,389 |
| Share capital transactions | 94 | - | - | (94) | - | - | - |
| Free share allocation plan and stock option plan | - | 365 | - | - | 365 | - | 365 |
| Treasury share transactions | - | - | 11 | - | 11 | - | 11 |
| Dividends | - | - | - | - | - | - | - |
| Net income for the period | - | - | (32) | (293) | (325) | (72) | (397) |
| Items of comprehensive income | - | - | - | 81 | 81 | 1 | 81 |
| CONSOLIDATED COMPREHENSIVE INCOME | - | - | (32) | (212) | (244) | (72) | (316) |
| Changes in scope | - | - | - | (198) | (198) | 198 | - |
| JUNE 2021 CLOSING EQUITY | 25,632 | 85,404 | (124) | (47,314) | 63,599 | (150) | 63,449 |
| (in thousands of euros) | Group share or owners of the parent company | ||||||
|---|---|---|---|---|---|---|---|
| Capital | Share capital reserves | Treasury shares | and earnings excluding Consolidated reserves treasury shares |
Equity attributable to owners of the parent |
minority interests or non- Equity attributable to controlling interests |
Total equity | |
| 2021 CLOSING EQUITY | 25,632 | 85,617 | (131) | (46,307) | 64,812 | 41 | 64,853 |
| Share capital transactions | - | - | - | - | - | - | - |
| Free share allocation plan and stock option plan | - | 138 | - | - | 138 | - | 138 |
| Treasury share transactions | - | - | 16 | - | 16 | - | 16 |
| Dividends | - | - | - | - | - | - | - |
| Net income for the period | - | - | 6 | 3,464 | 3,469 | 2 | 3,470 |
| Items of comprehensive income | - | - | - | 459 | 459 | (5) | 454 |
| CONSOLIDATED COMPREHENSIVE INCOME | - | - | 6 | 3,923 | 3,928 | (3) | 3,925 |
| Changes in scope | - | - | - | - | - | - | - |
| JUNE 2022 CLOSING EQUITY | 25,632 | 85,755 | (106) | (42,388) | 68,893 | 38 | 68,931 |
The condensed half-year consolidated financial statements of the PRODWAYS GROUP cover a period of six months, from 1 January to 30 June 2022. They were approved by the Board of Directors on 14 September 2022.
The Group notes seasonal variations in its activities that may affect the level of revenue from one half-year to another. Thus, the interim results are not necessarily indicative of those that can be expected for the full year.
The highlights of the first half of the year are described in the activity report.
The Group prepares half-year consolidated financial statements in accordance with IAS 34 "Interim financial information". They do not include all the information required for the preparation of the annual financial statements and should be read in conjunction with the consolidated financial statements for the financial year ended on 31 December 2021, as they appear in the Universal Registration Document approved by the French Financial Markets Authority (Autorité des Marchés Financiers – AMF) on 27 April 2022.
The accounting principles used for the preparation of the half-year consolidated financial statements comply with the regulations and interpretations of the International Financial Reporting Standards (IFRS) as adopted by the European Union as of 30 June 2022. These accounting principles are consistent with those used in the preparation of the annual consolidated financial statements for the financial year ended on 31 December 2021.
The Group has applied all standards, amendments and interpretations that are mandatory for financial years beginning after 1 January 2022:
The new standards, interpretations and amendments to existing standards and applicable to accounting periods beginning on or after 1 January 2022 were not adopted early by the Group on 1 January 2022. They concern:
These new standards are being analyzed by the Group when they are applicable to it.
The financial statements are prepared on a historical cost basis, with the exception of derivative instruments and available-for-sale financial assets, which have been measured at fair value. Other financial assets and liabilities are measured at amortized cost. Hedging instruments are measured at fair value.
The preparation of the financial statements requires that Executive Management of the Group or the subsidiaries make estimates and assumptions that affect the reported amounts of assets and liabilities on the consolidated statement of financial position, the reported amounts of income and expense items on the income statement and the commitments relating to the period under review. Actual subsequent results may differ.
The above-mentioned assumptions mainly concern:
As the Group's consolidated companies operate in different sectors, the valuation and impairment methods used for certain items may vary according to the sector.
The valuation methods and rules applied to the half-year consolidated financial statements are similar to those described in the notes to the consolidated financial statements for 2021 (please see the Company's Universal Registration Document approved by the AMF on 27 April 2022).
The full list of consolidated companies is included in Note 14.
The Group did not experience any change in the scope of consolidation during the half-year.
In accordance with IFRS 8 – Operating segments, the segment information presented below is based on the internal reporting used by Executive Management to assess the performance of and allocate resources to the various segments. Executive Management is the principal operational decision maker within the meaning of IFRS 8.
The two divisions defined as operating segments are the following (main companies):
The key indicators by division presented in the tables below are the following:
The Group uses non-IFRS financial information for the purposes of information, management and planning because they offer a better assessment of its long-term performance. This additional information is not a substitute for any IFRS measures of operating and financial performance.
Operating income includes all income and expenses other than:
To make it easier to compare financial years and monitor operating performance, the Group has decided to isolate certain items of operating income and present an "Operating result" (formerly "Current operating income"). It also uses a current EBITDA indicator. These non-accounting indicators do not constitute financial aggregates defined by IFRS; they are alternative performance indicators. They may not be comparable to similarly named indicators by other companies, depending on the definitions used by them.
The 2022 and 2021 segment income statements are reconciled below with the Group's consolidated financial statements. They are prepared in accordance with the Group's operational reporting.
The aggregates between operating income and net income are not tracked by segment in the Group's operational reporting.
FIRST HALF OF 2022
| (in thousands of euros) | SYSTEMS | PRODUCTS | Structure and disposals |
Consolidated |
|---|---|---|---|---|
| Backlog at start of period | 9,198 | 1,069 | (92) | 10,175 |
| Backlog at the end of the period | 8,667 | 1,290 | (4) | 9,953 |
| REVENUE | 26,420 | 15,253 | (204) | 41,470 |
| Capitalized production | 1,043 | 74 | - | 1,116 |
| Inventories and work in progress | (78) | 189 | - | 111 |
| Other income from operations | 936 | 131 | - | 1,066 |
| Purchases consumed | (14,404) | (6,612) | 568 | (20,448) |
| Personnel expenses | (7,927) | (6,638) | (732) | (15,298) |
| Tax and duties | (120) | (192) | (15) | (326) |
| Other operating expenses net of income | 131 | 98 | (35) | 195 |
| Current EBITDA | 6,001 | 2,303 | (418) | 7,886 |
| % revenue | 22.7% | 15.1% | n/s | 19.0% |
| Depreciation, amortization and provisions (net of reversals) | (1,042) | (1,519) | 68 | (2,494) |
| OPERATING RESULT | 4,959 | 783 | (350) | 5,393 |
| % revenue | 18.8% | 5.1% | n/s | 13.0% |
| Payment in shares | - | - | (175) | (175) |
| Restructuring costs | 107 | (16) | - | 92 |
| Amort. of intangible assets recognized at FV during acquisitions | (279) | (50) | - | (328) |
| Exceptional provisions for impairment of asset values | (11) | 30 | - | (19) |
| Other | - | - | - | - |
| Total other operating income | (183) | (35) | (175) | (393) |
| Group share of the earnings of affiliated companies | - | 71 | - | 71 |
| OPERATING INCOME | 4,776 | 820 | (525) | 5,071 |
| % revenue | 18.1% | 5.4% | n/s | 12.2% |
| Research and development expenses capitalized during the financial year |
1,043 | 31 | - | 1,074 |
| Other property, plant and equipment and intangible investments(1) | 135 | 326 | 68 | 529 |
(1) Does not include rights of use (IFRS 16).
| (in thousands of euros) | SYSTEMS | PRODUCTS | Structure and disposals |
Consolidated |
|---|---|---|---|---|
| Backlog at start of period | 5,630 | 949 | (13) | 6,566 |
| Backlog at the end of the period | 7,990 | 1,372 | (9) | 9,353 |
| REVENUE | 21,582 | 12,574 | (37) | 34,118 |
| Capitalized production | 611 | 34 | - | 645 |
| Inventories and work in progress | (560) | 29 | - | (531) |
| Other income from operations | 1,014 | 91 | - | 1,105 |
| Purchases consumed | (11,249) | (5,539) | 462 | (16,326) |
| Personnel expenses | (7,818) | (5,558) | (820) | (14,196) |
| Tax and duties | (95) | (267) | (10) | (372) |
| Other operating expenses net of income | 34 | 43 | (16) | 60 |
| Current EBITDA | 3,519 | 1,407 | (422) | 4,503 |
| % revenue | 16.3% | 11.2% | n/s | 13.2% |
| Depreciation, amortization and provisions (net of reversals) | (1,011) | (1,409) | 113 | (2,307) |
| OPERATING RESULT | 2,508 | (2) | (310) | 2,196 |
| % revenue | 11.6% | 0.0% | n/s | 6.4% |
| Payment in shares | - | - | (458) | (458) |
| Restructuring costs | (404) | 74 | (100) | (430) |
| Amort. of intangible assets recognized at FV during acquisitions | (272) | (50) | - | (321) |
| Exceptional provisions for impairment of asset values | 9 | (139) | (39) | (169) |
| Other | - | - | (9) | (9) |
| Total other operating income | (667) | (114) | (645) | (1,425) |
| Group share of the earnings of affiliated companies | - | 82 | - | 82 |
| OPERATING INCOME | 1,841 | (34) | (954) | 852 |
| % revenue | 8.5% | -0.3% | n/s | 2.5% |
| Research and development expenses capitalized during the financial year |
611 | 24 | - | 635 |
| Other property, plant and equipment and intangible investments(1) | 93 | 297 | 109 | 499 |
(1) Does not include rights of use (IFRS 16).
| (in thousands of euros) | France | % | Europe | % | North America |
% | Other | % | Total revenue |
% |
|---|---|---|---|---|---|---|---|---|---|---|
| Systems | 15,099 | 58% | 5,623 | 59% | 3,390 | 96% | 2,309 | 98% | 26,420 | 64% |
| Products | 11,214 | 43% | 3,869 | 41% | 123 | 4% | 47 | 2% | 15,253 | 37% |
| Structure and disposals | (244) | -1% | 41 | 0% | - | - | - | - | (204) | 0% |
| TOTAL | 26,068 | 100% | 9,532 | 100% | 3,513 | 100% | 2,357 | 100% | 41,470 | 100% |
| % | 63% | 23% | 8% | 6% | 100% |
| (in thousands of euros) | France | % | Europe | % | North America |
% | Other | % | Total revenue |
% |
|---|---|---|---|---|---|---|---|---|---|---|
| Systems | 11,599 | 51% | 6,172 | 83% | 2,801 | 97% | 1,010 | 96% | 21,582 | 63% |
| Products | 11,150 | 49% | 1,303 | 17% | 80 | 3% | 41 | 4% | 12,574 | 37% |
| Structure and disposals | (37) | 0% | - | - | - | - | - | - | (37) | 0% |
| TOTAL | 22,712 | 100% | 7,474 | 100% | 2,881 | 100% | 1,051 | 100% | 34,118 | 100% |
| % | 67% | 22% | 8% | 3% | 100% |
| (in thousands of euros) | 30/06/2022 | 30/06/2021 | 31/12/2021 |
|---|---|---|---|
| DEPRECIATION, AMORTIZATION AND PROVISIONS | |||
| Intangible assets | (374) | (324) | (679) |
| Property, plant and equipment | (872) | (952) | (1,911) |
| Rights of use | (1,114) | (1,007) | (2,118) |
| SUBTOTAL | (2,360) | (2,283) | (4,707) |
| CHARGES TO PROVISIONS, NET OF REVERSALS | |||
| Inventory and work in progress | (57) | (24) | 64 |
| Current assets | (100) | 122 | 430 |
| Liabilities and expenses | 23 | (122) | (278) |
| SUBTOTAL | (134) | (24) | 216 |
| TOTAL NET CHARGES TO DEPRECIATION, AMORTIZATION AND PROVISIONS | (2,494) | (2,307) | (4,491) |
| 30/06/2022 | 30/06/2021 | 31/12/2021 | ||||
|---|---|---|---|---|---|---|
| (in thousands of euros) | Gross value | Impairment losses | Net value | Net value | Net value | |
| Raw materials | 4,725 | (646) | 4,079 | 2,741 | 3,054 | |
| Work in progress | 826 | - | 826 | 604 | 650 | |
| Semi-finished and finished goods | 949 | (74) | 875 | 1,457 | 1,427 | |
| Goods | 2,383 | (158) | 2,225 | 1,253 | 1,371 | |
| INVENTORY AND WORK IN PROGRESS | 8,883 | (878) | 8,006 | 6,055 | 6,502 |
As part of its restructuring projects initiated in 2020, the Group scrapped these impaired assets during the half-year for €1.6 million.
Trade receivables are invoiced receivables entitling the issuer to payment.
"Contract assets" and "Contract liabilities" are determined on a contract-by-contract basis. "Contract assets" correspond to contracts in force for which the value of created assets exceeds the advances received. "Contract liabilities" correspond to all contracts in a situation where the assets (receivables in progress) are less than the liabilities (advances from clients and deferred income recorded when the invoices issued exceed the revenue recognized to date). These headings result from the application of IFRS 15.
The backlog (revenue to be recognized) is indicated by division in Note 3.1.
| (in thousands of euros) | 30/06/2022 | 30/06/2021 | 31/12/2021 |
|---|---|---|---|
| Trade receivables | 13,786 | 12,161 | 12,798 |
| Impairment losses | (723) | (931) | (623) |
| TRADE ACCOUNTS RECEIVABLE, NET VALUES | 13,063 | 11,230 | 12,175 |
| CONTRACT ASSETS | 48 | - | 20 |
| CONTRACT LIABILITIES | 2,086 | 617 | 1,585 |
| 31/12/2021 | ||||
|---|---|---|---|---|
| (in thousands of euros) | Gross value | Depreciation | Net value | Net value |
| Advances and down-payments made | 153 | - | 153 | 75 |
| Other receivables | 322 | - | 322 | 644 |
| Social and tax receivables | 1,168 | - | 1,168 | 1,323 |
| Prepaid expenses | 1,154 | - | 1,154 | 1,006 |
| TOTAL OTHER CURRENT RECEIVABLES | 2,796 | - | 2,796 | 3,049 |
| (in thousands of euros) | 30/06/2022 | 31/12/2021 |
|---|---|---|
| Suppliers | 7,697 | 9,155 |
| Fixed asset suppliers | - | - |
| SUPPLIER TOTALS | 7,697 | 9,155 |
| Advances and down-payments received | 275 | 75 |
| Social security liabilities | 5,375 | 5,718 |
| Tax liabilities | 1,950 | 2,490 |
| Miscellaneous debts | 643 | 975 |
| Deferred income related to the Research Tax Credit | 3,488 | 3,015 |
| TOTAL OTHER CURRENT LIABILITIES | 11,731 | 12,273 |
The deferred income includes subsidies and research tax credits (RTC), which partially or totally cover the cost of an asset, and are recognized in the income statement at the same rate as the asset's depreciation.
The leases restated under IFRS 16 had a total asset value of €6.9 million and a very limited impact of €124 thousand on the income statement (Group share). In accordance with IFRS 16, the lease expenses are replaced by a depreciation expense for assets known as "Right-of-use assets" amounting to €1,114 thousand (of which €67 thousand relating to finance leases that would have been valued in accordance with IAS 17) and by an interest charge on liabilities related to leases amounting to €42 thousand at 30 June 2022. Over the half-year, reversals of provisions amounting to €131 thousand were recorded following the termination of several property contracts. The movements during the half-year are detailed in the table below:
| (in thousands of euros) | Property | Other property, plant and equipment |
Prepaid payments | Total net assets | Lease liabilities on the liabilities side of the statement of financial position |
|---|---|---|---|---|---|
| AT 1 JANUARY 2022 | 6,021 | 1,228 | (38) | 7,212 | 7,477 |
| New leases | 519 | 205 | 724 | 724 | |
| Changes in scope | - | - | - | - | - |
| Amortization of rights of use | (752) | (362) | (1,114) | ||
| Impairment of right-of-use assets | 131 | - | 131 | ||
| Interest expenses | 41 | ||||
| Change in accrued interest | (1) | ||||
| Payments | 4 | 4 | (1,152) | ||
| Contract withdrawals/revaluations | (110) | (9) | (119) | (113) | |
| Translation differences | 79 | - | - | 79 | 79 |
| AT 30 JUNE 2022 | 5,888 | 1,062 | (34) | 6,916 | 7,057 |
| of which lease liabilities due in less than one year | 1,701 | ||||
of which lease liabilities due in more than one year 5,356
The application of IFRS 16 therefore has a significant impact on EBITDA as defined by the Group (see Note 3.1), with no significant impact on operating income and even less significant on net income. The current EBITDA for the half-year, which amounted to €7,886 thousand, would have amounted to €6,738 thousand without the application of IFRS 16.
| 30/06/2022 | 30/06/2021 | 31/12/2021 | |
|---|---|---|---|
| Systems | 197 | 214 | 195 |
| Products | 241 | 238 | 256 |
| Structure | 11 | 10 | 9 |
| TOTAL WORKFORCE | 450 | 462 | 460 |
| AVERAGE WORKFORCE | 449 | 467 | 468 |
The long-term provisions related solely to retirement benefits for an amount of €690 thousand. For this half-year, the assumptions used were the same as at 31 December 2021 except for the benchmark IBOXX 10+ discount rate, which changed from 0.98% to 3.22%. The impact on shareholders' equity for the period, due to this rate increase, was -€325 thousand (SORIE).
PRODWAYS GROUP set up free share allocation plans in 2016, 2019 and 2021.
Definitive acquisitions of new PRODWAYS GROUP shares for which the vesting conditions were met took place in April 2019 (261,900 shares of the 2016 plan) and in February 2021 (186,408 shares of the 2019 plan). There are potential shares under the 2019 and 2021 plans; the table below summarizes the situation of the two plans.
| Free share allocation plans | FSA 02-2021 | FSA 01-2019 |
|---|---|---|
| Original number of recipients | 371 | 446 |
| Support share | PRODWAYS GROUP | PRODWAYS GROUP |
| Potential number of shares | 550,550 | 802,800 |
| Final allocations in the year/cancellations | - / 2,095 | - / 18,840 |
| Cumulative final allocations/cancellations | - / 294,083 | 186,408 / 512,129 |
| Potential share balance | 256,467 | 104,263 |
| Date of establishment | February 2021 | January 2019 |
| Start of the vesting period | February 2021 | January 2019 |
| End of the vesting period | February to July 2023 | February 2021 to February 2023 |
| End of the lock-up period | February to July 2023 | February 2021 to February 2023 |
| Total expense recognized excluding social charges (in thousands of euros) | 402 | 860 |
| Potential value of the shares (in thousands of euros) | 662 | 331 |
| (in thousands of euros) | 30/06/2022 | 31/12/2021 |
|---|---|---|
| NET VALUE | ||
| AT 1 JANUARY | 41,831 | 38,094 |
| Acquisitions(1) | - | 3,737 |
| Departures | - | - |
| AT 30 JUNE | 41,831 | 41,831 |
| Of which accumulated impairment | - | - |
| Of which Systems | 63% | 63% |
| Of which Products | 37% | 37% |
(1) First consolidation in 2021 concerns the acquisition of CREABIS in the PRODUCTS division.
| (in thousands of euros) | Development projects | Other intangible assets | Non-current assets in progress |
TOTAL |
|---|---|---|---|---|
| GROSS VALUE | ||||
| AT 1 JANUARY 2022 | 16,283 | 13,454 | - | 29,737 |
| Acquisitions | 1,074 | 115 | 34 | 1,223 |
| Changes in scope | - | - | - | - |
| Departures | (4,521) | (269) | - | (4,790) |
| Other changes | - | 215 | - | 215 |
| Impact of changes in exchange rates | 362 | 155 | - | 517 |
| AT 30 JUNE 2022 | 13,199 | 13,671 | 34 | 26,904 |
| DEPRECIATION, AMORTIZATION AND IMPAIRMENT |
||||
| AT 1 JANUARY 2022 | 11,991 | 6,714 | - | 18,704 |
| Depreciation and amortization | 257 | 445 | - | 702 |
| Changes in scope | - | - | - | - |
| Impairment losses | (754) | - | - | (754) |
| Departures | (3,748) | (269) | - | (4,017) |
| Other changes | - | 215 | - | 215 |
| Impact of changes in exchange rates | 59 | 57 | - | 117 |
| AT 30 JUNE 2022 | 7,805 | 7,162 | - | 14,967 |
| NET VALUE | ||||
| AT 1 JANUARY 2022 | 4,293 | 6,740 | - | 11,033 |
| AT 30 JUNE 2022 | 5,394 | 6,509 | 34 | 11,936 |
As part of its restructuring projects initiated in 2020, the Group had identified certain assets to be impaired and recognized the corresponding provisions. Several of these assets were located on the Les Mureaux site, where the Group was a tenant until 30 June. As part of the departure from this site and during this half-year, the Group scrapped these impaired and fully depreciated assets for €4.8 million. The net impact of the disposals of the Group's intangible assets for the period was €0.8 million.
There was no indication of impairment in the first half of 2022.
| (in thousands of euros) | Land and buildings |
Fixtures and equipment |
Rights of use – property |
Rights of use – other assets |
Non-current assets in progress |
TOTAL |
|---|---|---|---|---|---|---|
| GROSS VALUE | ||||||
| At 1 January 2022 | 7,203 | 19,381 | 9,874 | 3,808 | 235 | 40,501 |
| Acquisitions | 14 | 340 | 519 | 205 | 26 | 1,104 |
| Changes in scope | - | - | - | - | - | - |
| Departures | - | (3,192) | (624) | (122) | - | (3,938) |
| Other changes | - | 358 | (109) | (2) | (13) | 234 |
| Impact of changes in exchange | ||||||
| rates | 21 | 242 | 149 | - | 19 | 430 |
| At 30 June 2022 | 7,238 | 17,129 | 9,809 | 3,890 | 267 | 38,332 |
| DEPRECIATION, | ||||||
| AMORTIZATION AND | ||||||
| IMPAIRMENT | ||||||
| At 1 January 2022 | 1,167 | 16,086 | 3,853 | 2,580 | - | 23,686 |
| Depreciation and amortization | 196 | 343 | 752 | 362 | - | 1,653 |
| Changes in scope | - | - | - | - | - | - |
| Impairment losses | - | (111) | (131) | - | - | (241) |
| Departures | - | (2,729) | (623) | (115) | - | (3,466) |
| Other changes | - | 346 | - | - | - | 346 |
| Impact of changes in exchange | - | |||||
| rates | 21 | 224 | 70 | - | 315 | |
| At 30 June 2022 | 1,384 | 14,160 | 3,921 | 2,827 | - | 22,292 |
| NET VALUE | ||||||
| At 1 January 2022 | 6,036 | 3,295 | 6,021 | 1,228 | 235 | 16,815 |
| At 30 June 2022 | 5,854 | 2,969 | 5,888 | 1,062 | 267 | 16,039 |
As part of its move from the Les Mureaux site, the Group scrapped these impaired and fully depreciated assets for €2.9 million over the half-year. The net impact of the disposals of property, plant and equipment for the period was €0.5 million.
| Start of the | Changes in | Change over | Other | Translation | |||
|---|---|---|---|---|---|---|---|
| (in thousands of euros) | Notes | period | scope | the year | movements(1) | differences | CLOSING |
| Net inventories | 6,502 | - | 1,306 | - | 198 | 8,006 | |
| Net receivables | 12,175 | - | 835 | - | 52 | 13,063 | |
| Contract assets | 20 | - | 28 | - | - | 48 | |
| Advances and down-payments | 75 | - | 78 | - | - | 153 | |
| Prepaid expenses | 1,006 | - | 134 | - | 13 | 1,154 | |
| SUBTOTAL | A | 19,778 | - | 2,381 | - | 264 | 22,423 |
| Trade payables | 9,155 | - | (1,521) | - | 63 | 7,697 | |
| Contract liabilities | 1,585 | - | 501 | - | - | 2,086 | |
| Advances and down-payments | 75 | - | 187 | - | 14 | 275 | |
| Deferred income | 2,677 | - | 443 | - | 41 | 3,161 | |
| SUBTOTAL | B | 13,493 | - | (390) | - | 117 | 13,219 |
| WORKING CAPITAL | C = A - B | 6,285 | - | 2,771 | - | 147 | 9,204 |
| Social and tax receivables | 3,125 | - | (95) | - | 2 | 3,033 | |
| Other receivables | 644 | - | (322) | - | - | 322 | |
| SUBTOTAL | D | 3,770 | - | (417) | - | 2 | 3,355 |
| Tax and social debts | 8,378 | - | (603) | - | 42 | 7,818 | |
| Other payables and derivative instruments(1) |
965 | - | (395) | (225) | 298 | 643 | |
| Deferred income CIR and subsidies | 338 | - | (10) | - | - | 327 | |
| SUBTOTAL | E | 9,681 | - | (1,008) | (225) | 340 | 8,788 |
| OTHER ITEMS OF WORKING CAPITAL | F = D - E | (5,911) | - | 591 | 225 | (338) | (5,433) |
| WORKING CAPITAL | G = C + F | 374 | - | 3,362 | 225 | (190) | 3,770 |
(1) The "Other movements" column contains cash flows that do not generate cash movements or any reclassifications between items.
The cash flows recorded on the line "Acquisitions/disposals of equity holdings" relate to acquisitions or disposals of shares in subsidiaries on the occasion of a change of control.
In July 2021, the Group acquired CREABIS. The acquisition contract provided for an earn-out based on the Company's performance in the 2021 to 2023 financial years, and a first earn-out of €225 thousand was paid in the first half of 2022.
The cash flows recorded on the line "Other equity transactions" concern the acquisitions or disposals of securities of PRODWAYS GROUP or of companies controlled by PRODWAYS GROUP (flows that do not result in a change of control), as well as the cash flows related to purchases and sales of treasury shares under the PRODWAYS GROUP liquidity contract.
| (in thousands of euros) | 30/06/2022 | 31/12/2021 |
|---|---|---|
| Proceeds | 22 | - |
| Payments | - | (43) |
| TOTAL | 22 | (43) |
In the first half of the year, three new loans were taken out with PRODWAYS GROUP, each for €1.5 million. Only two of them had been paid out as of 30 June 2022.
Three credit facility agreements were also signed for a total of €7.5 million.
The first tranche of the financing received by SOLIDSCAPE under the PPP program (\$0.9 million) benefited from a total abandonment by the US federal government in 2022.
The State-guaranteed loans set up in 2020 (€8.4 million in total) will be amortized over four years.
| (in thousands of euros) | Bank borrowings | Other borrowings | FINANCIAL DEBT | Bank overdrafts | GROSS FINANCIAL DEBT(2) |
|---|---|---|---|---|---|
| AT 1 JANUARY 2022 | 15,568 | 164 | 15,732 | 20 | 15,752 |
| Issue / subscription of new loans | 2,917 | 51 | 2,968 | 26 | 2,994 |
| Redemptions | (727) | (5) | (731) | (20) | (751) |
| Other changes(1) | (811) | - | (811) | - | (811) |
| First consolidation/Deconsolidation | - | - | - | - | - |
| Impact of changes in exchange rates | 28 | - | 28 | - | 28 |
| AT 30 JUNE 2022 | 16,975 | 210 | 17,185 | 27 | 17,212 |
(1) Changes with no impact on cash flow, related to effective interest rates and accrued interest on loans, as well as a debt write-off of \$0.9 million from which SOLIDSCAPE benefited.
(2) Does not include the lease liability calculated in accordance with IFRS 16.
The "Other borrowings" include repayable advances received by the Group in respect of research and development in particular. These advances cannot be repaid, or only repaid partially according to the success of the operations on the basis of which they were granted.
| Of which breakdown of maturities at more than one year | ||||||||
|---|---|---|---|---|---|---|---|---|
| (in thousands of euros) | 30/06/2022 | < 1 year | > 1 year | 1 to 2 years | 2 to 3 years | 3 to 4 years | 4 to 5 years | > 5 years |
| Bank borrowings | 16,975 | 2,757 | 14,218 | 3,371 | 3,090 | 2,769 | 1,555 | 3,433 |
| Other borrowings | 210 | 4 | 206 | 9 | 9 | 9 | 9 | 171 |
| FINANCIAL DEBT EXCLUDING CURRENT BANK OVERDRAFTS |
17,185 | 2,761 | 14,424 | 3,379 | 3,099 | 2,777 | 1,564 | 3,604 |
| Bank overdrafts | 27 | 27 | - | - | - | - | - | - |
| GROSS FINANCIAL DEBT | 17,212 | 2,787 | 14,424 | 3,379 | 3,099 | 2,777 | 1,564 | 3,604 |
| (in thousands of euros) | 30/06/2022 | 31/12/2021 |
|---|---|---|
| AVAILABLE CASH AND CASH EQUIVALENTS (A) | 18,868 | 16,917 |
| Bank overdrafts (B) | 27 | 20 |
| CASH (C) = (A) - (B) | 18,841 | 16,897 |
| Financial debt (D) | 17,185 | 15,732 |
| NET CASH (DEBT) (C) - (D) | 1,656 | 1,165 |
| Treasury shares | 118 | 134 |
| ADJUSTED NET CASH (NET DEBT) BEFORE IFRS 16 | 1,774 | 1,299 |
Lease liabilities valued according to IFRS 16 have changed as follows:
| (in thousands of euros) | Lease liabilities |
|---|---|
| AT 1 JANUARY 2022 | 7,475 |
| New leases | 724 |
| Redemptions | (1,109) |
| Other changes(1) | (112) |
| First consolidation/Deconsolidation | - |
| Impact of changes in exchange rates | 79 |
| AT 30 JUNE 2022 | 7,057 |
(1) Changes with no impact on cash, related to accrued interest and revaluation of contracts.
| Amounts due in more than one year | ||||||||
|---|---|---|---|---|---|---|---|---|
| (in thousands of euros) | 30/06/2022 | < 1 year | > 1 year | 1 to 2 years | 2 to 3 years | 3 to 4 years | 4 to 5 years | > 5 years |
| LEASE LIABILITIES UNDER IFRS 16 | 7,057 | 1,701 | 5,356 | 1,358 | 1,102 | 849 | 711 | 1,336 |
The movements over the year are as follows:
| (in thousands of euros) | Start of the period |
Income | Translation differences |
Changes in scope |
Other | Closing |
|---|---|---|---|---|---|---|
| BIOTECH DENTAL SMILERS | 1,213 | 71 | - | - | - | 1,285 |
PRODWAYS GROUP has four revolving credit lines of €2.5 million each with three banking institutions. The three new lines complete the €2.5 million line which expires in December 2022. They are confirmed, on a decreasing basis, until 31 December 2025 and are not used to date.
| (in thousands of euros) | 30/06/2022 | 30/06/2021 | 31/12/2021 |
|---|---|---|---|
| Interest expense | (71) | (50) | (122) |
| Interest expenses on lease liabilities | (41) | (41) | (85) |
| Income from other securities | - | - | 2 |
| Net income on sales of transferable securities | - | 3 | (206) |
| Cost of net debt | (112) | (88) | (39) |
| Other interest income | (23) | (10) | 69 |
| Net exchange gain or loss | 39 | 20 | - |
| Financial allowances net of reversals | - | - | (176) |
| FINANCIAL INCOME AND EXPENSES | (97) | (78) | (122) |
| Breakdown of tax expense | |||
|---|---|---|---|
| (in thousands of euros) | 30/06/2022 | 30/06/2021 | 31/12/2021 |
| Deferred tax liabilities | (651) | (474) | 213 |
| Taxes payable | (853) | (697) | (1,267) |
| TAX EXPENSE | (1,504) | (1,171) | (1,054) |
The income tax expense does not include the Research Tax Credit (CIR) classified as "Other income from operations". However, it includes the Corporate Value Added Contribution (CVAE).
Tax receivables and payable
| (in thousands of euros) | 30/06/2022 | 31/12/2021 |
|---|---|---|
| Tax receivables | 1,865 | 1,802 |
| Tax payable | 493 | 161 |
| NET TAX RECEIVABLE/(DUE) | 1,372 | 1,641 |
Tax receivables mainly consist of receivables for the Research Tax Credit and the Competitiveness and Employment Tax Credit which could not be offset against tax payable.
Breakdown of deferred taxes by type
| (in thousands of euros) | 30/06/2022 | 31/12/2021 |
|---|---|---|
| DIFFERENCES OVER TIME | ||
| Retirement and related benefits | 105 | 164 |
| Development costs | (1,185) | (966) |
| Leases | 33 | 68 |
| Fair value – IFRS 3 | (1,388) | (1,435) |
| Other | 41 | 8 |
| SUBTOTALS | (2,395) | (2,161) |
| Other temporary differences | 128 | 108 |
| Deficits carried forward | 2,453 | 3,011 |
| TOTAL | 186 | 958 |
| DEFERRED TAX LIABILITIES | (684) | (538) |
| DEFERRED TAX ASSETS | 870 | 1,496 |
Deferred tax assets are recognized in respect of tax loss carryforwards if the tax loss carryforwards can be offset against the existence of deferred tax liabilities and then based on reasonable prospects of being charged against future profits within a three-year period. Almost 55% of deferred tax assets recognized in respect of tax loss carryforwards are due to the existence of deferred tax liabilities.
Shareholders whose shares have been registered for more than two years may benefit from double voting rights.
At 30 June 2022, the share capital of PRODWAYS GROUP SA amounted to €25,631,975.50, consisting of 51,263,951 fully paid-up shares, each with a nominal value of €0.50, of which 8,052,665 have double voting rights.
| 30 June 2022 | 31 December 2021 | |||||||
|---|---|---|---|---|---|---|---|---|
| Shares | % of share of capital |
Voting rights exercisable at SM(1) |
% of voting rights exercisable at SM |
Shares | % of share of capital |
Voting rights exercisable at SM(1) |
% of voting rights exercisable at SM |
|
| PÉLICAN VENTURE | 11,089,087 | 21.63% | 11,089,087 | 18.71% | 11,089,087 | 21.63% | 11,089,087 | 18.71% |
| GROUPE Gorgé | 3,050,210 | 5.95% | 6,000,420 | 10.12% | 3,050,210 | 5.95% | 6,000,420 | 10.12% |
| Raphaël Gorgé | 173,964 | 0.34% | 173,964 | 0.29% | 177,472 | 0.35% | 177,472 | 0.30% |
| Jean-Pierre Gorgé | 173,048 | 0.34% | 173,048 | 0.29% | 173,113 | 0.34% | 173,113 | 0.29% |
| Sub-total Gorgé family |
14,486,309 | 28.26% | 17,436,519 | 29.41% | 14,489,882 | 28.27% | 17,440,092 | 29.42% |
| Fimalac Développement |
3,403,508 | 6.64% | 6,807,016 | 11.48% | 3,403,508 | 6.64% | 6,807,016 | 11.48% |
| Safran Corporate Venture |
907,894 | 1.77% | 1,565,788 | 2.64% | 907,894 | 1.77% | 1,565,788 | 2.64% |
| Bpifrance Participations |
750,000 | 1.46% | 1,500,000 | 2.53% | 750,000 | 1.46% | 1,500,000 | 2.53% |
| Treasury shares | 38,791 | 0.076% | - | - | 45,458 | 0.09% | - | - |
| Public | 31,531,251 | 61.51% | 31,676,106 | 53.44% | 31,667,209 | 61.77% | 31,965,954 | 53.43% |
| TOTAL | 51,263,951 | 100.00% | 59,277,825 | 100.00% | 51,263,951 | 100% | 59,278,850 | 100% |
(1) The voting rights exercisable at SM exclude treasury shares. The number of theoretical votes may be obtained by adding the number of votes exercisable at the shareholders' meeting to the number of treasury shares.
Due to the existence of free share allocation plans in progress, there are 360,730 potential shares.
| 30/06/2022 | 30/06/2021 | 31/12/2021 | |
|---|---|---|---|
| Weighted average number of shares | 51,225,160 | 51,220,596 | 51,218,493 |
| EARNINGS PER SHARE (in euros) | 0.068 | (0.006) | 0.012 |
| EARNINGS PER SHARE FROM ONGOING ACTIVITIES (in euros) | 0.068 | (0.006) | 0.012 |
| Dilutive potential shares(1) | 360,730 | 410,162 | 363,200 |
| Diluted weighted average number of shares | 51,585,890 | 51,220,596 | 51,581,693 |
| DILUTED EARNINGS PER SHARE (in euros) | 0.067 | (0.006) | 0.012 |
| DILUTED EARNINGS PER SHARE FROM ONGOING ACTIVITIES (in euros) | 0.067 | (0.006) | 0.012 |
(1) To date, free share allocations are currently the only type of instrument outstanding with a potentially dilutive effect. To the extent that accounting for the dilutive effect of free shares would have decreased the loss per share, the diluted earnings per share is equal to the basic earnings per share for the period until 30 June 2021.
| Short-term provisions (in thousands of euros) |
Litigation | Customer warranties | Other | Total |
|---|---|---|---|---|
| AT 1 JANUARY 2022 | 712 | - | 215 | 927 |
| Appropriations | - | - | 16 | 16 |
| Provisions used | - | - | (116) | (116) |
| Reversals | (7) | - | (18) | (25) |
| IMPACT ON THE NET INCOME FOR THE PERIOD | (7) | - | (118) | (125) |
| Impact of changes in exchange rates | - | - | 4 | 4 |
| AT 30 JUNE 2022 | 705 | - | 101 | 806 |
Related parties are persons (Directors or managers of PRODWAYS GROUP or its main subsidiaries) or entities owned or managed by these persons.
| in thousands of euros, in the Group's financial statements |
GROUPE Gorgé | |
|---|---|---|
| Income statement | ||
| Revenue | - | 119 |
| Other income | - | - |
| Purchases and external charges | (324) | (3) |
| Statement of financial position | ||
| Trade receivables | - | 83 |
| Trade payables | - | - |
| Other liabilities | 74 | 21 |
| Debtors | - | - |
| Loans | - | - |
| Guarantee deposits received | - | - |
The company PRODWAYS GROUP is chaired by Mr. Raphaël Gorgé, who is also a Director and Chairperson and Chief Executive Officer of GROUPE Gorgé.
The Group's commitments, as they appear in the notes to the consolidated financial statements for 2021, have not changed significantly.
The Company and its subsidiaries are involved in various litigation proceedings. After reviewing each case and seeking counsel, the provisions considered necessary have, as applicable, been recorded in the financial statements.
There are no significant changes in litigation compared with the information given in the notes to the consolidated financial statements at 31 December 2021.
On 6 July 2022, the acquisition of the French company AUDITECH, a French specialist in customized hearing protection, was announced. In 2021, the company generated revenue close to €3 million and was profitable. It will be consolidated in the second half of the year in the PRODUCTS division. No other significant events took place between 30 June 2022 and the date of the Board of Directors meeting that approved the consolidated financial statements.
| Parent company | % control | % interest | Method | ||||
|---|---|---|---|---|---|---|---|
| Company | At 30 June 2022 | 2022 | 2021 | 2022 | 2022 | 2021 | |
| Consolidating company | |||||||
| PRODWAYS GROUP SA | Top | Top | Top | Top | FC | FC | |
| Structure | |||||||
| PRODWAYS ENTREPRENEURS(1) | PRODWAYS GROUP | 100 | 100 | 100 | 100 | FC | FC |
| PRODWAYS 2(1) | PRODWAYS GROUP | 100 | 100 | 100 | 100 | FC | FC |
| SYSTEMS | |||||||
| 3D SERVICAD | AS 3D | 100 | 100 | 100 | 100 | FC | FC |
| AVENAO SOLUTIONS 3D | PRODWAYS GROUP | 100 | 100 | 100 | 100 | FC | FC |
| AVENAO INDUSTRIE | AS 3D | 100 | 100 | 100 | 100 | FC | FC |
| DELTAMED (Germany) | PRODWAYS GROUP | 100 | 100 | 100 | 100 | FC | FC |
| EXCELTEC | PRODWAYS GROUP | 100 | 100 | 100 | 100 | FC | FC |
| PRODWAYS | PRODWAYS GROUP | 100 | 100 | 100 | 100 | FC | FC |
| PRODWAYS CONSEIL | PRODWAYS GROUP | 100 | 100 | 100 | 100 | FC | FC |
| PRODWAYS MATERIALS (Germany) | DELTAMED | 100 | 100 | 100 | 100 | FC | FC |
| PRODWAYS RAPID ADDITIVE | |||||||
| FORGING | PRODWAYS GROUP | 100 | 100 | 100 | 100 | FC | FC |
| NEXTCUBE.IO | AS 3D | 64.67 | 64.67 | 64.67 | 64.67 | FC | FC |
| SOLIDSCAPE (United States) | PRODWAYS GROUP | 100 | 100 | 100 | 100 | FC | FC |
| PRODUCTS | |||||||
| CREABIS (Germany)(2) | INITIAL | 100 | 100 | 100 | 100 | FC | FC |
| CRISTAL | PRODWAYS GROUP | 100 | 100 | 100 | 100 | FC | FC |
| PRODWAYS | |||||||
| BIOTECH DENTAL SMILERS | ENTREPRENEURS | 20 | 20 | 20 | 20 | EM | EM |
| INITIAL | PRODWAYS GROUP | 100 | 100 | 100 | 100 | FC | FC |
| INTERSON PROTAC | PRODWAYS GROUP | 100 | 100 | 100 | 100 | FC | FC |
| PODO 3D | PRODWAYS GROUP | 100 | 100 | 100 | 100 | FC | FC |
| SCI CHAVANOD | PRODWAYS GROUP | 100 | 100 | 100 | 100 | FC | FC |
| VARIA 3D (United States) | PRODWAYS GROUP | 70 | 70 | 70 | 70 | FC | FC |
(1) Companies with no activities.
(2) CREABIS was acquired in July 2021; it was only consolidated for six months in 2021.
(period from 1 January to 30 June 2022)
63 rue de Villiers 92208 Neuilly-sur-Seine Cedex RSM PARIS
26 rue Cambacérès 75008 Paris
Registered office: 30 rue de Gramont – 75002 PARIS Public limited company with capital of €25,631,975.50
In accordance with the mission entrusted to us by your Shareholders' Meeting and pursuant to Article L. 451 1 2 III of the French Monetary and Financial Code, we have:
These condensed half-year consolidated financial statements were prepared under the responsibility of the Board of Directors. Our role is to express a conclusion on these financial statements based on our review.
We conducted our review in accordance with the professional standards applicable in France.
A limited review consists mainly of meeting with the members of management in charge of accounting and financial aspects and implementing analytical procedures. This work is less extensive than that required for an audit conducted in accordance with the professional standards applicable in France. Consequently, the assurance that the financial statements, taken as a whole, are free from material misstatement obtained during a limited review is a moderate assurance, lower than that obtained in the context of an audit.
Based on our limited review, we did not identify any material misstatements that would call into question the compliance of the condensed half-year consolidated financial statements with IAS 34, the IFRS standard as adopted in the European Union, on interim financial information.
We have also verified the information provided in the half-year management report commenting on the condensed half-year consolidated financial statements on which our limited review was based.
We have no matters to report as to their fair presentation and their consistency with the consolidated financial statements.
Signed in Neuilly-sur-Seine and Paris, on 14 September 2022
The Statutory Auditors
PricewaterhouseCoopers Audit RSM PARIS
Christophe Drieu Stéphane Marie
I certify, to the best of my knowledge, that the condensed consolidated financial statements for the past half-year are prepared in accordance with the applicable accounting standards and give a true and fair view of the assets, financial position and results of the company and of all the companies included in the consolidation, and that the above half-year activity report presents a true and fair view of the significant events that occurred during the first six months of the financial year, their impact on the financial statements, the main transactions between related parties and a description of the main risks and uncertainties for the remaining six months of the financial year.
Mickaël OHANA, Chief Executive Officer
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.